GSD News and Press, WisdomTree Global SmallCap Dividend Fund From 10/03/23

GSD - DarkPulse, Inc. Provides Letter to Shareholders from CEO

HOUSTON, Oct. 03, 2023 (GLOBE NEWSWIRE) -- DarkPulse, Inc. (OTC: DPLS) (“DarkPulse”, “DPLS", or "the Company") today issued a letter to shareholders from CEO Dennis O’Leary. A Letter to Shareholders from the Founder & CEO of DarkPulse, Inc. Dear fello...

GSD - Devonian Announces Closing of a Private Placement of $500,000

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, ...

GSD - Global System Dynamics, Inc. Announces Rescheduled Special Meeting

HOUSTON, July 27, 2023 (GLOBE NEWSWIRE) -- Global System Dynamics, Inc. (Nasdaq: GSD) (“GSD” or the “Company”) today announced that the special meeting of its stockholders (the “Special Meeting”) originally scheduled for Monday, July 31, 2023 is being res...

GSD - Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease.

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB : DVHGF ), a clinical late stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, , is ...

GSD - Devonian Announces Closing of a Private Placement of $1.2 Million

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

GSD - Devonian Announces Private Placement of up to $5 Million

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

GSD - Devonian Health Group Announces Presentation of Thykamine(TM) Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine(TM) Clinical Development Program Update.

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXv: GSD; OTCQB : DVHGF ), a clinical late stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today...

GSD - Devonian Health Group Announces the Appointment of New Board Members and Grant of Stock Options

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXv: GSD; OTCQB : DVHGF ), a clinical late stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, annou...

GSD - Devonian Announces Filing of Preliminary Base Shelf Prospectus

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

GSD - Devonian Announces Approval of Amendments to its Stock Option Plan and its Restricted Share Unit Plan

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

Company Name:	WisdomTree Global SmallCap Dividend Fund
Stock Symbol:	GSD
Market:	NASDAQ